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Abstract
Background: In lung disease, physical activity (PA) yields beneficial health effects, but its association with the function
of healthy lungs has rarely been studied. We investigated the association of accelerometer-based PA with spirometric
indices, maximal inspiratory mouth pressure (PImax) and lung diffusion capacity in lung-healthy adults.
Methods: In total, 341 apparently lung-healthy participants from the population-based KORA (Cooperative Health
Research in the Region of Augsburg) FF4 cohort study (45% male, aged 48-68 years, 47% never smokers) completed
lung function testing and wore ActiGraph accelerometers over a one week period at the hip. In adjusted regression
analyses, moderate to vigorous PA (MVPA) was characterized as: sex-specific activity quartiles, achieving ≥ 10 consecutive
minutes (yes vs. no), and meeting the WHO PA recommendations (yes vs. no).
Results: Positive associations of MVPA-quartiles with forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC),
and corresponding Global Lung Function Initiative z-scores were found. Subjects in the most active quartile (> 47 or >
50 min/day for females and males, respectively) had 142 ml [95% CI: 23, 260] higher FEV1 and 155 ml [95% CI: 10, 301]
higher FVC than those in the least active quartile (< 17 or < 21 min/day for females and males, respectively); however
these associations were stronger among ex−/current smokers. Achieving at least once 10 consecutive minutes of
MVPA was only associated with higher PImax [β-estimate: 0.57 kPa; 95% CI: 0.04, 1.10], remaining significant among
never smokers. No associations were found with diffusion capacity or for reaching the WHO-recommended 150 min of
MVPA/week in 10-min bouts.
Conclusions: Although the effects were small, active subjects showed higher spirometric results. The observed
associations were more pronounced among ever smokers suggesting a higher benefit of PA for subjects being at a
higher risk for chronic lung diseases.
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Background
Physical activity (PA) reduces the risk of premature mor-
tality and chronic diseases like cardiovascular disease or
diabetes mellitus [1]. Benefits of activity apply also to
persons with chronic lung diseases such as asthma or
chronic obstructive pulmonary disease (COPD), who are
therefore encouraged to engage in regular PA [2, 3].
Studies have shown that higher PA was associated with a
lower risk of hospital admissions and all-cause mortality
in COPD patients [3, 4]. Furthermore, the diffusion cap-
acity of the lung for carbon monoxide was shown to be
a predictor of a decline in 6-min-walking distance in
COPD patients [5]. Moreover, exercise training in COPD
patients was associated with improved ventilatory
muscle function and showed positive effects on the
forced vital capacity (FVC) [6, 7]. Due to the positive
health effects of PA in patients with chronic lung
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diseases, PA has been incorporated into pulmonary
rehabilitation programs [8].
In population-based studies, PA was shown to be asso-
ciated with slower age-related decline of the forced ex-
piratory volume in 1 s (FEV1) in adults [9, 10]. Results
from a longitudinal study among middle-aged men
showed that those with higher levels of PA experienced
slower lung function decline over 25 years [11]. How-
ever, all these studies assessed PA by questionnaires,
which was found to correlate only low-to-moderately
with activity objectively assessed by motion sensors in
adults [12, 13].
Only a few studies have investigated the association of
accelerometer-based PA with lung function. Moreover,
the association between PA and lung function in lung-
healthy persons is unclear. In lung-healthy adolescents,
no associations were found between accelerometer-
based PA and a broad range of spirometric parameters
[14]. In adults, results of a study among 62 smokers
showed that lung function between inactive participants,
defined as those who engaged in less than 150 min/week
of moderate to vigorous PA (MVPA), and active ones
did not differ [15]. Thus, the evidence is inconclusive.
Furthermore, studies among athletes suggest that
endurance exercise is associated with higher FVC and
improved lung diffusion capacity [16, 17]. A study
among 25 healthy men showed an improvement of max-
imal inspiratory pressure after 5 weeks of inspiratory
muscle training [18], as observed in COPD patients after
exercise training [6], whereas the increase in respiratory
muscle endurance of marathon runners was described as
a consequence of differences in breathing pattern devel-
oped during running rather than respiratory muscle
strength [19].
Considering the limited evidence on the association
between PA and lung function in lung-healthy popula-
tions, our aim was to investigate the association of
accelerometer-based PA with lung function in apparently
lung-healthy German adults from a population-based
sample. Therefore, we addressed different aspects of
lung function i.e. lung volume, airflow limitation,
pulmonary gas exchange (TLCO/VA) and inspiratory
muscle strength (PImax).
Methods
Study population
The present analysis was based on a follow-up study of the
KORA S4 (KORA: Cooperative Health Research in the Re-
gion of Augsburg) cohort comprising 4261 adults (51.0%
female) examined in 1999 – 2001. A description of the
primary study design has been published previously [20].
The selection of the study population is displayed in
detail in Fig. 1. In the KORA FF4 follow-up study 2279
participants (51.6% female) aged 38-88 years were exam-
ined between June 2013 and September 2014. Covering
only the age range 48-68 years, 1043 of these partici-
pants were selected for the “Lung health & physical ac-
tivity” study, which comprised spirometry, assessment of
Fig. 1 Selection of participants. KORA: Cooperative Health Research in the Region of Augsburg. ATS: American Thoracic Society. ERS: European
Respiratory Society. COPD: chronic obstructive pulmonary disease. FEV1: forced expiratory volume in 1 s. FVC: forced vital capacity. TLCO/VA:
transfer factor of the lung for carbon monoxide adjusted for hemoglobin and divided by alveolar volume. PImax: maximum inspiratory mouth pressure
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inspiratory muscle strength (PImax), measures of
pulmonary gas exchange, and accelerometer-based
assessment of habitual PA over one week. Information
on sociodemographic variables, and current medication
intake seven days before examination was obtained from
standardized interviews and questionnaires. For the
assessment of common diseases such as stroke or myo-
cardial infarction, subjects were asked for each disease
separately if a doctor has ever diagnosed this particular
disease. Further, information on mobility and pain/dis-
comfort was obtained from the EuroQol five dimensions
questionnaire (EQ-5D 5 L) [21].
Of 1010 subjects who participated in spirometry, spi-
rometric data of 990 participants were considered as
valid based on international recommendations [22]. In
accelerometry, two males with values greater than the
mean plus seven times the standard deviation for weight
and MVPA, respectively, were excluded during data
management after quality control, resulting in 477
subjects with valid accelerometric data out of 562 who
initially participated. For the selection of lung-healthy
subjects, 465 subjects who had both, valid spirometry
and accelerometry were considered. Subjects who re-
ported a doctor’s diagnosis of asthma, emphysema,
chronic bronchitis or COPD, or used pulmonary medi-
cation including antileukotrienes, inhaled sympathomi-
metics, anticholinergics, and/or steroids were excluded
from this analysis (N = 71). Furthermore, subjects with
FEV1/FVC < 0.7 (indication of airflow limitation) were
excluded (N = 53) [23]. Finally, 341 apparently lung-
healthy subjects were available for the present analysis.
Among these, PImax results were available for 331 sub-
jects (54.7% female) and results for the transfer factor of
the lung for carbon monoxide divided by alveolar
volume (TLCO/VA) for 322 subjects (54.3% female).
Physical activity assessment
A detailed description of the procedure, data handling,
quality control and inclusion criteria has been reported
previously [24]. In brief, participants were asked to wear
an ActiGraph GT3X accelerometer (Pensacola, Florida)
over a one week period at the hip from getting up until
going to bed time and to complete a daily diary which
included the time of getting up, going to sleep, and rea-
sons for and duration of non-wear time. Non-wear time
according to the accelerometer data was assessed based
on the algorithm derived from the National Health and
Nutrition Examination Survey [25]. Days were consid-
ered as not valid, if the difference between the non-wear
time algorithm applied to the accelerometer data and
the diary non-wear time was greater than 60 min (if the
non-wear time was reported in the diary) or greater than
120 min (if the accelerometer indicated a non-wear
time). Subjects were excluded in case of no reported
non-wear time over the whole 7 day reporting period
although the accelerometer should have been removed
during water activities e.g. showering. Further exclusion
criteria for single days were missing information on time
spent awake, day length < 10 h/day, non-wear time dur-
ing sport activities lasting > 2 h, or incorrect handling of
the accelerometer e.g. hand instead of hip. Further
details of all exclusion criteria have been previously pub-
lished [24]. Subjects were only included in the analysis if
they had at least 3 valid weekdays and 1 valid weekend
day. 89% of the subjects included in our analysis re-
corded at least 6 days, 9% had 5 days and 2% provided
4 days only. Measured accelerations of the vertical axis
were stored at 1 Hz and converted into 1-min epochs
classifying a moderate to vigorous PA (MVPA) level as
≥ 1952 counts per minute, as proposed by Freedson et
al. [26]. Non-wear time during sport was imputed as
described here [14, 24].
Since the relationship between MVPA and lung function
measures adjusted for sex, age, and height was non-linear,
MVPA was divided into sex-specific quartiles. In addition,
two further binary PA variables were built based on the
World Health Organization (WHO) recommendation
stating that adults should accumulate at least 150 min
of MVPA/week in bouts of at least 10 min [27].
PA was quantified as exposure in three ways: (1) sex-
specific MVPA quartiles; (2) achieving at least one 10-min
bout of MVPA over the whole measurement period (yes
vs. no); (3) reaching the WHO threshold of 150 min
MVPA/week in at least 10-min bouts (yes vs. no). Cut-offs
for sex-specific MVPA quartiles were set as follows: cut-
off for males: 1st ≤ 21.6 min/day, 2nd > 21.6-35.2 min/day,
3rd > 35.2-49.9 min/day, 4th > 49.9 min/day; and cut-offs
for females: 1st ≤ 17.2 min/day, 2nd > 17.2-28.3 min/day,
3rd > 28.3-46.7 min/day, 4th > 46.7 min/day, respectively.
Lung function assessment
Lung function assessment was performed in line with
the American Thoracic Society (ATS) and European Re-
spiratory Society (ERS) statements [22, 28, 29].
Flow-volume curves were obtained using a pneumo-
tachograph-type spirometer (MasterScope, Jaeger, Hoech-
berg, Germany). Subjects were guided to perform at least
3 and up to 8 spirometric maneuvers per test in order to
obtain acceptable and reproducible values. During the ma-
neuvers both flow-volume and volume-time curves were
monitored online by a trained examiner. After each test,
the curves were visually inspected, artifacts e.g. coughing
were excluded and the results were selected and evaluated
according to the ATS/ERS recommendations [22], includ-
ing a good start with extrapolated volume < 0.5% of FVC
or 0.15 l, an exhalation of ≥ 6 s or a plateau in volume-
time curve. Spirometric parameters included FEV1, FVC,
FEV1/FVC, and forced expiratory flow between 25% and
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75% of exhaled FVC (FEF25-75). Standardized z-scores
were calculated using reference equations for spirometry
from the Global Lung Function Initiative (GLI) [30].
TLCO was determined using the single-breath technique.
Subjects were asked to perform a maximum of 5 trials in
order to achieve acceptable and reproducible values with
an inspired volume > 85% of the largest vital capacity in
<4 s, and an effective breath hold time within 8 to 12 s ac-
cording to ATS/ERS recommendations [28]. TLCO results
were adjusted for hemoglobin obtained from blood sam-
ples collected on the day of the physical examination in
the study center [28]. For determination of PImax, subjects
were instructed to exhale to residual volume followed by a
maximal voluntary inspiration against an obstructed
mouth piece with a small leak to prevent glottic closure
using a flanged mouth piece [29]. The highest peak
inspiratory pressure achieved during a minimum of 3 and
a maximum of 15 maneuvers was used for analysis
(MasterScreen PFT, Jaeger, Hoechberg, Germany).
Statistical analyses
Sex-specific differences were assessed using Pearson’s
Chi-squared test (categorical variables), the t-test (nor-
mal distribution), and Wilcoxon rank-sum test
(skewed distribution). Mean and corresponding standard
deviation or percentages (%, N) were used to describe
subject characteristics and categorized PA. Due to a
non-normal distribution, median and 1st and 3rd
quartiles were reported for continuous MVPA.
Adjusted linear regression models were applied to
analyze associations between PA and lung function pa-
rameters. Since spirometric parameters (FEV1, FVC, and
FEF25-75) were correlated (r = 0.61 to 0.98), the results of
regression analyses were not adjusted for multiple test-
ing. For each spirometric parameter, the mean plus/
minus 4 times the standard deviation was calculated for
each sex to determine sex-specific outliers. According to
this definition one subject was excluded in the analyses
using z-scores for FEV1 and FVC and another in FEF25-
75 models. The main model was adjusted for sex, age,
height, weight, smoking status categorized as never, ex-,
or current smokers, education level categorized as low
(<10 years of school, i. e. “Hauptschule” in Germany),
middle (10 years of school, i.e. “Realschule”) and high
(>10 years of school, i.e. “Gymnasium”), and a doctor’s
diagnosis of hay fever (ever). Regression models for stan-
dardized GLI z-scores [30] that are already adjusted for
ethnicity, sex, age, and height, were adjusted only for
additional variables. Covariates remained in the model
independent of statistical significance. As the mean body
mass index (BMI) was 27.7 kg/m2 we included a
sensitivity analysis, replacing weight with BMI in the
main analysis.
To assess if the association might be modified through
other covariates potentially associated with lung func-
tion, sensitivity analyses were done. Since smoking be-
havior has an impact on lung function and might modify
potential associations, we calculated the main regression
model with stratification into never and ex−/current
smokers. In further analyses, the main model was
additionally adjusted for moderate to extreme problems
in walking about and/or pain or discomfort, season cate-
gorized as winter (start of measurement: December to
February), spring (March to May), summer (June to
August), and autumn (September to November), or for
self-reported acute respiratory infections in the last three
weeks prior to lung function testing. All participants
were Caucasian therefore ethnicity was not included as a
covariate. Interaction effects between MVPA and sex
were tested in the main model. In case of significant
interaction effects (p < 0.05), stratified results were
reported additionally.
To eliminate a possible impact of myocardial infarc-
tion and/or stroke (N = 15), subjects with a history of
these events were excluded from the main model as a
further sensitivity analysis.
The statistical program R, version 3.3.3 [31], was used
for all analyses and p-values below 0.05 were considered
statistically significant.
Results
The study population consisted of 341 (45% male) appar-
ently lung-healthy subjects (i.e. no chronic lung diseases
or pulmonary medication intake, and FEV1/FVC ≥ 0.7)
with a mean age of 57 years (Table 1). The prevalence of
current smoking was 14%, while 47% of the participants
reported to be never smokers. Despite a lower prevalence
of females among all ex−/current smokers than among
never smokers (50.0% and 61.6%, respectively), 70.2% of
current smokers were female. BMI was comparable be-
tween never and ex−/current smokers. Mean z-scores
were lower among ex−/current smokers compared to
never smokers, being statistically significant for z-score
FEF25-75. Nevertheless, smoking status did not affect PA
(Additional file 1: Table S1). Included subjects were
slightly younger (mean age of 57 years vs. 58 years,
respectively) and more often never smokers (46.6% vs.
37.8%, respectively) compared to all other subjects
performing spirometry (Additional file 1: Table S2).
Overall, participants spent a median of 31 min/day in
MVPA with a range from 1 to 111 mean min/day, being
lower for females than for males (median 28 vs. 35 min,
respectively). In total, 66% of subjects achieved at least
one 10-min bout of MVPA, and 15% achieved the rec-
ommended 150 min of MVPA/week in at least 10-min
bouts (Table 1).
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Table 1 Population characteristics, lung function and physical activity measurements
Males (n = 152) Females (n = 189)
Age
mean years (SD) 57.1 (5.8) 57.5 (5.3)
Height *
mean cm (SD) 177.0 (6.0) 162.1 (6.0)
Weight *
mean kg (SD) 88.8 (13.5) 71.5 (14.4)
BMI*
n normal (BMI < 25) (%) 27 (17.8) 79 (41.8)
n overweight (≥ 25 BMI <30) (%) 83 (54.6) 61 (32.3)
n obese (BMI ≥ 30) (%) 42 (27.6) 49 (25.9)
Smoking status*
n never smokers (%) 61 (40.1) 98 (51.9)
n ex-smokers (%) 77 (50.7) 58 (30.7)
n current smokers (%) 14 (9.2) 33 (17.5)
Education*
n low (< 10 years of school) (%) 68 (44.7) 84 (44.4)
n medium (10 years of school) (%) 34 (22.4) 66 (34.9)
n high (> 10 years of school) (%) 50 (32.9) 39 (20.6)
Hay fever
n yes (%) 22 (14.5) 43 (22.8)
Problems in walking about, and/or pain or discomfort
n not at all/slight (%) 135 (88.8) 154 (81.9)
n moderate/extreme (%) 17 (11.2) 34 (18.1)
Lung function
FEV1*
mean l (SD) 3.76 (0.57) 2.66 (0.42)
FVC*
mean l (SD) 4.88 (0.71) 3.39 (0.56)
FEV1/FVC*
mean % (SD) 77.08 (3.93) 78.5 (4.14)
FEF25-75*
mean l/s (SD) 3.16 (0.91) 2.37 (0.63)
Z-score FEV1
mean (SD) 0.25 (0.86) 0.32 (0.91)
Z-score FVC
mean (SD) 0.29 (0.80) 0.35 (0.87)
Z-score FEV1/FVC
mean (SD) −0.12 (0.58) −0.15 (0.63)
Z-score FEF25-75
mean (SD) −0.01 (0.78) −0.01 (0.80)
TLCO, hemoglobin adjusted*
mean mmol/min/kPa (SD) 9.88 (1.50) 6.90 (1.07)
TLCO/VA*
mean mmol/min/kPa/l (SD) 1.45 (0.16) 1.38 (0.18)
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Physical activity and spirometric parameters
In the total population, being in the most active MVPA
quartile was associated with higher FEV1, FVC, FEV1 z-
score and FVC z-score (Table 2, Additional file 1: Table
S3). FEV1 was 142 ml higher in the most active subjects,
i.e. females that engaged > 47 min/day and males that
engaged > 50 min/day in MVPA, than in the least active
quartile, i.e. < 17 min/day for females or < 21 min/day
for males. Stratified analyses revealed that these associa-
tions remained in ex−/current smokers, but not in never
smokers (Table 2).
The results for FVC were comparable to those observed
for FEV1, except for an interaction effect between the
third MVPA quartile and sex that was present for FVC
only. After stratification an association was found for fe-
males only (Additional file 1: Table S4). Sensitivity ana-
lyses, e.g. further adjustment for walking difficulties and/
or discomfort, and exclusion of subjects with stroke and/
or myocardial infarction did not substantially change our
results. Adjusting for BMI instead of weight led to the very
similar results (Additional file 1: Table S5).
When MVPA was quantified as achieving at least
one 10-min bout, an association with lung function
was found in sex-stratified analyses for FEV1, FVC, z-
scores for FEV1 and FVC in females only
(Additional file 1: Tables S4 and S6). Reaching the
recommended 150 min of MVPA/week in at least 10-
min bouts was negatively associated with FEV1, FVC,
Table 1 Population characteristics, lung function and physical activity measurements (Continued)
Males (n = 152) Females (n = 189)
PImax*
mean kPa (SD) 9.77 (2.53) 6.67 (2.12)
Physical activity
MVPA*
median of mean min/day (1st; 3rd quartile) 35.2 (21.6; 49.9) 28.3 (17.2; 46.7)
10-min bout of MVPA achieved
n yes (%) 104 (68.4) 120 (63.5)
WHO threshold achieved
n yes (%) 24 (15.8) 26 (13.8)
SD standard deviation, BMI body mass index, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, FEF25-75 forced expiratory flow between 25% and 75%
of FVC, TLCO/VA transfer factor of the lung for carbon monoxide adjusted for hemoglobin and divided by alveolar volume, PImax maximum inspiratory mouth
pressure, MVPA moderate to vigorous physical activity
*p < 0.05 (males vs. females)
Table 2 Association of physical activity with spirometric parameters
MVPA Total population
(n = 341)
Never smokers
(n = 159)
Ex- and current smokers
(n = 182)
Quartilea β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
FEV1, ml 2 72 (−44, 188) 0.22 44 (−129, 218) 0.62 81 (−78, 240) 0.32
3 124 (7, 242) 0.04 167 (−7, 341) 0.06 60 (−104, 224) 0.47
4 142 (23, 260) 0.02 84 (−89, 257) 0.34 195 (29, 360) 0.02
FVC, ml 2 91 (−52, 235) 0.21 48 (−160, 256) 0.65 114 (−87, 316) 0.27
3 107 (−38, 251) 0.15 190 (−18, 398) 0.08 11 (−196, 219) 0.92
4 155 (10, 301) 0.04 75 (−132, 282) 0.48 227 (18, 437) 0.04
FEV1/FVC, % 2 0.01 (−1.18, 1.21) 0.98 −0.03 (−1.86, 1.80) 0.97 −0.10 (−1.72, 1.51) 0.90
3 0.87 (−0.34, 2.07) 0.16 0.33 (−1.50, 2.17) 0.72 1.07 (−0.59, 2.74) 0.21
4 0.64 (−0.57, 1.85) 0.30 0.70 (−1.12, 2.52) 0.45 0.56 (−1.12, 2.24) 0.51
FEF25-75, ml/s 2 100 (−120, 319) 0.37 61 (−266, 388) 0.71 101 (−201, 403) 0.51
3 277 (56, 499) 0.01 239 (−89, 566) 0.16 246 (−65, 558) 0.12
4 161 (−63, 384) 0.16 106 (−220, 433) 0.52 213 (−102, 527) 0.19
MVPA moderate to vigorous physical activity, CI confidence interval, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, FEF25-75 forced expiratory flow
between 25% and 75% of FVC
aLeast active MVPA quartile (1st quartile) was used as reference. All models were adjusted for sex, age, height, weight, education level, a doctor’s diagnosis of hay
fever and depending on the population analyzed also by smoking status (never, ex- or current)
Statistically significant associations (p < 0.05) are shown in bold
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and z-scores for FEV1 and FVC in males only
(Additional file 1: Tables S4 and S7).
Physical activity and inspiratory muscle strength
Subjects who engaged in at least one 10-min bout of
MVPA had an estimated increase of PImax by 0.6 kPA
(Table 3). However, in analyses stratified by smoking sta-
tus, this association was significant only in never
smokers (Additional file 1: Table S8).
Physical activity and pulmonary gas exchange
PA was not associated with TLCO/VA in any analysis,
except for a negative association found with the third
MVPA quartile among never smokers (Table 3,
Additional file 1: Table S8).
Discussion
The present analyses revealed weak positive associations
between the most active subjects and volumetric indices
in adults without lung function limitation. These associ-
ations were primarily observed among ex−/current
smokers, but not in never smokers, suggesting that the
effect might be driven by smoking behaviour. While PA
showed no association with TLCO/VA, PImax was higher
in subjects who engaged in at least one 10-min bout of
MVPA during the recording period, compared to those
who did not.
Compared to current recommendations PA was ra-
ther low in our population-based cohort. Median
daily MVPA was 31 min, and only 15% of subjects
met the WHO PA recommendation. This finding,
however, is comparable to results obtained through
the questionnaire-based German Health Interview and
Examination Survey for Adults where 18% of 50-
69 year old participants achieved the WHO activity
threshold [32].
Still, weak associations with lung function were
present in our analyses.
An association between PImax and the achievement of
at least one 10-min bout of MVPA was found in our
population, remaining significant in never smokers only.
In COPD, twitch mouth pressure has previously been
shown to decrease with increasing disease severity and
PImax could be improved by exercise training [6, 33]. A
study among marathon athletes compared to sedentary
controls reported a higher respiratory muscle endurance
in the athletes - probably as a result of breath technique,
but a similar PImax [19].
In our population, those who reached at least one 10-
min bout spent in MVPA showed a higher PImax, while
reaching the WHO PA recommendation showed no in-
crease. It might be that the threshold of engaging for at
least 10 consecutive minutes in habitual MVPA, i.e. sep-
arating subjects with short bouts of activity and those
with at least sporadic activity for 10 min, might repre-
sent a plateau. However, this result should be interpreted
with caution due to the weak associations found and the
potentially minor clinical relevance.
While TLCO has previously been shown to be a clinic-
ally relevant predictor of exercise capacity determined
by 6-min-walking distance test in COPD patients [5], PA
was not found to be a predictor of TLCO/VA in our ap-
parently lung-healthy population. The lack of findings
might be due to the possibly small effects that could not
be detected in habitual PA of middle-aged adults
without lung function limitation.
Our results show a weak, but positive association of
PA and volumetric lung function indices, primarily seen
among ex−/current smokers. Compared to the least ac-
tive subjects, subjects engaging on average more than
about 48 min/day in MVPA had a 142 ml higher FEV1.
Considering an annual decline of around 25 ml of FEV1
Table 3 Association of physical activity with pulmonary gas exchange and inspiratory muscle strength
Pulmonary gas exchange (TLCO/VA), 10−1 mmol/min/kPa/l Maximum inspiratory mouth pressure (PImax), kPa
β (95% CI) p-value β (95% CI) p-value
MVPA quartiles,
1st – least active (reference) – – – –
2nd 0.01 (−0.47, 0.49) 0.98 0.39 (−0.32, 1.10) 0.28
3rd −0.30 (−0.80, 0.19) 0.23 0.23 (−0.48, 0.94) 0.53
4th – most active 0.25 (−0.25, 0.75) 0.33 0.05 (−0.68, 0.78) 0.90
10-min bout of MVPA achieved,
yes vs. no −0.03 (−0.39, 0.34) 0.88 0.57 (0.04, 1.10) 0.04
WHO threshold achieved,
yes vs. no 0.36 (−0.13, 0.84) 0.15 0.00 (−0.71, 0.71) 1.00
The models were adjusted for sex, age, height, weight, smoking status categorized as never, ex-, or current smokers, education level, and a doctor’s diagnosis of
hay fever
TLCO/VA transfer factor of the lung for carbon monoxide adjusted for hemoglobin and divided by alveolar volume, PImax maximum inspiratory mouth pressure, CI
confidence interval, MVPA moderate to vigorous physical activity
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in adults [34, 35], our results would correspond to an
age-related decline of about 5 years. No causal relation-
ships or long-term effects can be drawn from our cross-
sectional analysis, but our results are in line with those
from a longitudinal study observing that current
smokers with moderate and high PA had a decreased de-
cline in FEV1 and FVC compared with smokers with low
PA [36]; and as in our study, this association was not ob-
served in never smokers. A study including only
smokers did not find an association between the
achievement of at least 150 min/week of MVPA and spi-
rometric parameters [15]. However, observed differences
may be related to diverse designs, population character-
istics and definitions of being active [15, 36]. PA was
suggested to promote an anti-inflammatory status and
to potentially protect against chronic diseases associated
with low-grade systemic inflammation [37]. Smokers are
at a higher risk for COPD and other smoking-related
diseases typically experiencing a low-grade systemic in-
flammation [38]. In our analysis, the positive associa-
tions between being active and volumetric indices were
more pronounced among ex−/current smokers, suggest-
ing a higher benefit of PA for subjects being at a higher
risk for chronic lung diseases.
Strength and limitations
A major strength of this study is the investigation of a
range of standardized lung function parameters obtained
by spirometry, as well as less often investigated measures
of gas exchange and respiratory muscle strength in
apparently lung-healthy adults. We objectively assessed
PA by accelerometry, which is rare, as most available
studies assessed PA by questionnaires [9–11, 36].
Evidence for the association between PA and lung
function in the general population without chronic lung
diseases is likewise rare.
Due to the cross-sectional design of our analysis, it is
not possible to draw conclusions about long-term effects
or causal relations. Although associations were found,
these results should be interpreted with caution due to
the small effects seen with partly wide confidence
intervals. Further, the present results are limited to the
pre-selected lung-healthy study population, comprising
48-68 year old residents in the region of Augsburg in
southern Germany. Information on chronic lung
diseases was assessed via self-report and was not indi-
vidually verified by a physician.
Conclusions
Objective measurements of physical activity showed a
weak, but positive association with slightly higher
volumetric lung function indices in lung-healthy adults
from southern Germany. This association was mainly
observed among ex−/current smokers. Further, engaging
in MVPA for at least 10 consecutive minutes was associ-
ated with higher PImax, remaining significant in never
smokers only. No associations were found for TLCO/
VA. Although the effects were small, our results suggest
a positive association of PA with lung function of lung-
healthy subjects from a population-based cohort.
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